German China India

UK/China: Biotechnology Collaboration

SZQH Sunflower & TRD Investment to Invest $470 Million in Biotechnology

| Editor: Ahlam Rais

The investment serves an example of the enhanced Golden Era in Sino-UK relations.
Gallery: 1 image
The investment serves an example of the enhanced Golden Era in Sino-UK relations. (Bild: Deposit Photos)

Claimed to be one of the biggest ever single investments into British innovation, Future Planet Capital, 8GT, SZQH Sunflower and TRD Investment have collaborated to promote technologies between the UK and China.

Beijing/China – Future Planet Capital, the global innovation platform connecting the world’s largest investors to the best minds in order to address global challenges has signed a Memorandum of Understanding with Eight Great Technologies Fund (8GT), Shenzhen Qian Hai Sunflower Financial Services (SZQH Sunflower) and Jian Xin Tian Ran Investment Management (TRD Investment) to collaborate on commercialising technologies and promoting innovation between the UK and China.

The agreement was signed during UK Prime Minister Theresa May’s state visit to China and witnessed by Secretary of State for International Trade Liam Fox and President of Chinese Health Information and Big Data Association Jin Xiaotao. It serves an example of the enhanced Golden Era in Sino-UK relations and is one of several recent commercial announcements, collectively worth around 1.9 billion dollars (£1.4 billion).

SZQH Sunflower and TRD Investment will in principle invest $470 million in healthcare innovation and bio-technology between the UK and China. Such collaborations may include the engagement with 8GT, in partnership with FPC, as well as investment into Eight Great Technologies China UK Technology Fund, a dedicated China-UK venture capital and growth fund.

Comments are being loaded ....

Leave a comment
  1. Avatar
    Avatar
    Edited by at
    Edited by at
    1. Avatar
      Avatar
      Edited by at
      Edited by at

Comments are being loaded ....

Report comment

Kommentar Freigeben

Der untenstehende Text wird an den Kommentator gesendet, falls dieser eine Email-hinterlegt hat.

Freigabe entfernen

Der untenstehende Text wird an den Kommentator gesendet, falls dieser eine Email-hinterlegt hat.

copyright

This article is protected by copyright. You want to use it for your own purpose? Infos can be found under www.mycontentfactory.de (ID: 45127872 / Pharma & Food)